Prelude Therapeutics Inc
NASDAQ:PRLD

Watchlist Manager
Prelude Therapeutics Inc Logo
Prelude Therapeutics Inc
NASDAQ:PRLD
Watchlist
Price: 1.3 USD 46.4% Market Closed
Market Cap: 71.6m USD
Have any thoughts about
Prelude Therapeutics Inc?
Write Note

Intrinsic Value

The intrinsic value of one PRLD stock under the Base Case scenario is 1.17 USD. Compared to the current market price of 1.3 USD, Prelude Therapeutics Inc is Overvalued by 10%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PRLD Intrinsic Value
1.17 USD
Overvaluation 10%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Prelude Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
PRLD
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for PRLD cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about PRLD?
Bearish
Neutral
Bullish

Fundamental Analysis

1.3 USD
+46.4%
+46.4%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Prelude Therapeutics Inc
US
Biotechnology
Market Cap
71.6m USD
IPO
Sep 25, 2020
Employees
116
United States of America
Market Cap
71.6m USD
Industry
Biotechnology
IPO
Sep 25, 2020
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Prelude Therapeutics Inc

Provide an overview of the primary business activities
of Prelude Therapeutics Inc.

What unique competitive advantages
does Prelude Therapeutics Inc hold over its rivals?

What risks and challenges
does Prelude Therapeutics Inc face in the near future?

Has there been any significant insider trading activity
in Prelude Therapeutics Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Prelude Therapeutics Inc.

Provide P/S
for Prelude Therapeutics Inc.

Provide P/E
for Prelude Therapeutics Inc.

Provide P/OCF
for Prelude Therapeutics Inc.

Provide P/FCFE
for Prelude Therapeutics Inc.

Provide P/B
for Prelude Therapeutics Inc.

Provide EV/S
for Prelude Therapeutics Inc.

Provide EV/GP
for Prelude Therapeutics Inc.

Provide EV/EBITDA
for Prelude Therapeutics Inc.

Provide EV/EBIT
for Prelude Therapeutics Inc.

Provide EV/OCF
for Prelude Therapeutics Inc.

Provide EV/FCFF
for Prelude Therapeutics Inc.

Provide EV/IC
for Prelude Therapeutics Inc.

Show me price targets
for Prelude Therapeutics Inc made by professional analysts.

What are the Revenue projections
for Prelude Therapeutics Inc?

How accurate were the past Revenue estimates
for Prelude Therapeutics Inc?

What are the Net Income projections
for Prelude Therapeutics Inc?

How accurate were the past Net Income estimates
for Prelude Therapeutics Inc?

What are the EPS projections
for Prelude Therapeutics Inc?

How accurate were the past EPS estimates
for Prelude Therapeutics Inc?

What are the EBIT projections
for Prelude Therapeutics Inc?

How accurate were the past EBIT estimates
for Prelude Therapeutics Inc?

Compare the revenue forecasts
for Prelude Therapeutics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Prelude Therapeutics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Prelude Therapeutics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Prelude Therapeutics Inc compared to its peers.

Compare the P/E ratios
of Prelude Therapeutics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Prelude Therapeutics Inc with its peers.

Analyze the financial leverage
of Prelude Therapeutics Inc compared to its main competitors.

Show all profitability ratios
for Prelude Therapeutics Inc.

Provide ROE
for Prelude Therapeutics Inc.

Provide ROA
for Prelude Therapeutics Inc.

Provide ROIC
for Prelude Therapeutics Inc.

Provide ROCE
for Prelude Therapeutics Inc.

Provide Gross Margin
for Prelude Therapeutics Inc.

Provide Operating Margin
for Prelude Therapeutics Inc.

Provide Net Margin
for Prelude Therapeutics Inc.

Provide FCF Margin
for Prelude Therapeutics Inc.

Show all solvency ratios
for Prelude Therapeutics Inc.

Provide D/E Ratio
for Prelude Therapeutics Inc.

Provide D/A Ratio
for Prelude Therapeutics Inc.

Provide Interest Coverage Ratio
for Prelude Therapeutics Inc.

Provide Altman Z-Score Ratio
for Prelude Therapeutics Inc.

Provide Quick Ratio
for Prelude Therapeutics Inc.

Provide Current Ratio
for Prelude Therapeutics Inc.

Provide Cash Ratio
for Prelude Therapeutics Inc.

What is the historical Revenue growth
over the last 5 years for Prelude Therapeutics Inc?

What is the historical Net Income growth
over the last 5 years for Prelude Therapeutics Inc?

What is the current Free Cash Flow
of Prelude Therapeutics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Prelude Therapeutics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Prelude Therapeutics Inc

Current Assets 156.4m
Cash & Short-Term Investments 153.6m
Other Current Assets 2.8m
Non-Current Assets 40.8m
PP&E 36.4m
Other Non-Current Assets 4.4m
Current Liabilities 22.2m
Accounts Payable 5.9m
Accrued Liabilities 15.1m
Other Current Liabilities 1.2m
Non-Current Liabilities 18.6m
Other Non-Current Liabilities 18.6m
Efficiency

Earnings Waterfall
Prelude Therapeutics Inc

Revenue
3m USD
Operating Expenses
-146.3m USD
Operating Income
-143.3m USD
Other Expenses
11.7m USD
Net Income
-131.5m USD

Free Cash Flow Analysis
Prelude Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PRLD Profitability Score
Profitability Due Diligence

Prelude Therapeutics Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

29/100
Profitability
Score

Prelude Therapeutics Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

PRLD Solvency Score
Solvency Due Diligence

Prelude Therapeutics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Prelude Therapeutics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PRLD Price Targets Summary
Prelude Therapeutics Inc

Wall Street analysts forecast PRLD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRLD is 5.51 USD with a low forecast of 1.01 USD and a high forecast of 10.5 USD.

Lowest
Price Target
1.01 USD
22% Downside
Average
Price Target
5.51 USD
324% Upside
Highest
Price Target
10.5 USD
708% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PRLD?

Click here to dive deeper.

Dividends

Prelude Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PRLD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

PRLD Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one PRLD stock?

The intrinsic value of one PRLD stock under the Base Case scenario is 1.17 USD.

Is PRLD stock undervalued or overvalued?

Compared to the current market price of 1.3 USD, Prelude Therapeutics Inc is Overvalued by 10%.

Back to Top